Literature DB >> 7909579

Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat striatum.

A J Smith1, J F McGinty.   

Abstract

The effects of a single dose of amphetamine or methamphetamine on opioid peptide gene expression in the dorsal and ventral striatum of rats were investigated by quantitative in situ hybridization 3, 6, or 18 h after injection. Although amphetamine-treated rats exhibited significantly different behaviors than those treated with methamphetamine, both drugs caused a patchy increase in preprodynorphin, but not preproenkephalin, mRNA in the caudate at all 3 time points. No changes were detected in the nucleus accumbens. These data indicate that prolonged elevation of preprodynorphin expression may alter the responsiveness of striatonigral neurons to subsequent amphetamine exposure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7909579     DOI: 10.1016/0169-328x(94)90268-2

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  10 in total

1.  Regulation of opioid gene expression in the rat brainstem by 3,4-methylenedioxymethamphetamine (MDMA): role of serotonin and involvement of CREB and ERK cascade.

Authors:  Manuela Di Benedetto; Sussy del Carmen Bastías Candia; Claudio D'Addario; Elena Elettra Porticella; Chiara Cavina; Sanzio Candeletti; Patrizia Romualdi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-23       Impact factor: 3.000

2.  Changes in gene expression linked to methamphetamine-induced dopaminergic neurotoxicity.

Authors:  Tao Xie; Liqiong Tong; Tanya Barrett; Jie Yuan; George Hatzidimitriou; Una D McCann; Kevin G Becker; David M Donovan; George A Ricaurte
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

3.  Acute nicotine changes dynorphin and prodynorphin mRNA in the striatum.

Authors:  Raffaella Isola; Hailin Zhang; Gopi A Tejwani; Norton H Neff; Maria Hadjiconstantinou
Journal:  Psychopharmacology (Berl)       Date:  2008-09-21       Impact factor: 4.530

Review 4.  Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature.

Authors:  Kelly E Courtney; Lara A Ray
Journal:  Drug Alcohol Depend       Date:  2014-08-17       Impact factor: 4.492

5.  Methamphetamine-induced behavioral sensitization in mice: alterations in mu-opioid receptor.

Authors:  Chi-Tso Chiu; Tangeng Ma; Ing K Ho
Journal:  J Biomed Sci       Date:  2006-07-18       Impact factor: 8.410

6.  κ Opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake.

Authors:  Timothy W Whitfield; Joel E Schlosburg; Sunmee Wee; Adam Gould; Olivier George; Yanabel Grant; Eva R Zamora-Martinez; Scott Edwards; Elena Crawford; Leandro F Vendruscolo; George F Koob
Journal:  J Neurosci       Date:  2015-03-11       Impact factor: 6.167

7.  Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats.

Authors:  Melissa L Perreault; Dawn Graham; Sarah Scattolon; Yufang Wang; Henry Szechtman; Jane A Foster
Journal:  Psychopharmacology (Berl)       Date:  2007-07-10       Impact factor: 4.530

Review 8.  Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants.

Authors:  Heinz Steiner; Vincent Van Waes
Journal:  Prog Neurobiol       Date:  2012-10-17       Impact factor: 11.685

9.  The Role of BDNF/TrkB Signaling in Acute Amphetamine-Induced Locomotor Activity and Opioid Peptide Gene Expression in the Rat Dorsal Striatum.

Authors:  Jacqueline F McGinty; Alexandra J Bache; Nortorious T Coleman; Wei-Lun Sun
Journal:  Front Syst Neurosci       Date:  2011-07-21

Review 10.  Enkephalin as a Pivotal Player in Neuroadaptations Related to Psychostimulant Addiction.

Authors:  Bethania Mongi-Bragato; María P Avalos; Andrea S Guzmán; Flavia A Bollati; Liliana M Cancela
Journal:  Front Psychiatry       Date:  2018-05-28       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.